Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Photosensitivity Disorders
and you are
between 30 and 70
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to determine whether 5-FU infusion (Microinfusion of Medicine Percutaneously - MMP) is effective for Idiopathic Guttate Hypomelanosis (IGH) repigmentation compared to conventional Microneedling. MMP is a procedure done with tattoo devices using medication in place of ink.

Provided treatments

  • Drug: MMP with 5-FU
  • Drug: MMP with Saline infusion
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02904564. The sponsor of the trial is Clinica Dermatologica Arbache ltda and it is looking for 30 volunteers for the current phase.
Official trial title:
Conventional Microneedling Compared to Microneedling Associated With 5-FU Infusion (Microinfusion of Medication Into the Skin - MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation